AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. T...

AstraZeneca has warned it might move its vaccine manufacturing site from the UK to the United States due to stalled discussions with the ne...

AstraZeneca's contract signed with the Commission on behalf of EU member states foresaw an initial 300 million doses for distribution among...

In the 50-share pack Nifty, M&M was the biggest gainer, up 2.05 per cent. UPL, TCS, HDFC, SBI, Tata Motors, Shree Cement, ITC, Infosys and ...

With banks in the lead, Europe's benchmark STOXX 600 index rose 0.7% after breaking a five-week winning streak to end 1% lower last week.

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.

If final-stage trial data show AstraZeneca’s candidate gives effective protection from the virus, the Serum Institute of India Ltd. -- whic...

The investment amount will be treated as an advance and once the vaccine receives regulatory approvals, SII will include Bangladesh among t...

Poonawalla said the company plans to make 70 million doses per month and increase this to 100 million. These will be used for phase 3 clini...

AstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc. about a potential merger.

As part of the agreement, AZ will sell the following brands of Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin a...

The company is also looking to develop additional technology centres with a second GTC planned for San Francisco in 2015.

Pfizer's potential takeover of AstraZeneca poses a threat to British science unless it can give more concrete, enforceable guarantees on jo...

In Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.

The decision to shut the R&D centre is part of an ongoing global restructuring exercise, said the company that employs over 1,200 people in...

AstraZeneca, the world's seventh largest drug maker by sales, is planning to delist its Indian subsidiary, said two people with knowledge o...

HCL will deliver server virtualisation, storage and backup transformation and implementation of hybrid cloud for the AstraZeneca.